EX-23.2 3 tv504397_ex23-2.htm EXHIBIT 23.2

Exhibit 23.2

 

 

Consent of Independent Registered Public Accounting Firm

 

 

Akari Therapeutics, Plc

London, United Kingdom

 

 

We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 23, 2016, relating to the combined and consolidated financial statements of Akari Therapeutics, Plc, which is incorporated by reference in that Prospectus.

 

We also consent to the reference to us under the caption “Experts” in the Prospectus.

 

 

Zurich, October 9, 2018

 

BDO AG

 

 

 

/s/ Christoph Tschumi  /s/ ppa. Aaron Fox-Collis
Christoph Tschumi  ppa. Aaron Fox-Collis